Open access
Aug 2026
Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells
It is shown that a subset of breast cancer cell lines and patient-derived xenografts express CD70, albeit to varying levels, and enhanced-sensitivity receptor designs such as HIT receptors to engage a broader range of tumors are highlighted.
P. Lindenbergh, V. Rajasekhar, I. Linkov et al.
· Frontiers in Immunology · 0 citations